Puma Biotechnology Boosted After FDA Approves Breast Cancer Therapy By: Benzinga via Benzinga July 18, 2017 at 08:25 AM EDT The U.S. Food and Drug Administration on Monday approved Puma Biotechnology Inc (NASDAQ: PBYI)'s NERLYNX (neratinib), formerly known ... Read More >> Related Stocks: Puma Biotechnology